Display 75 results
2 May 23
Regulatory, Finance Tax Investment, Pre Clinical And Clinical Research, Manufacturing, Overarching Political Issues, IP And Technology Transfer, Strategic Technologies, Skills People And Talent, Access To Medicines, News Report
Influencing and shaping our sector | BIA update: January - April 2023
Advocating for the life science and biotech sector: report on how BIA is influencing change with government stakeholders.
23 Jan 23
Regulatory, Finance Tax Investment, Pre Clinical And Clinical Research, Manufacturing, Overarching Political Issues, IP And Technology Transfer, Strategic Technologies, Skills People And Talent, Access To Medicines, Policy Briefing
Influencing and shaping our sector | BIA update: October 2022 - January 2023
20 Jan 23
Strategic Technologies, Consultation Response
BIA response to AMR national action plan call for evidence
The BIA has responded to the Department for Health and Social Care (DHSC)’s call for evidence on the next antimicrobial resistance (AMR) national action plan. Our response was developed with input from a range of BIA members working in the AMR space.
12 Dec 22
Strategic Technologies, Guidance document, Policy Briefing